1. Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;
2. Clinical Hematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt;
3. Rosalind and Morris Goodman Cancer Research Centre, Department of Oncology, Biochemistry and Medicine, McGill University, Montreal, QC, Canada;
4. Department of Hematology and Oncology, Faculty of Medical Science, University of Fukui, Fukui, Japan;
5. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; and
6. Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, and
7. Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH